These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39090803)

  • 1. The Comparison of Newly Diagnosed Invasive Breast Patient Cohorts in Genomics Evidence Neoplasia Information Exchange Biopharma Collaborative (GENIE-BPC) and Other Real-World Databases.
    Liu X; Alipour GH; Shao C; Burcu M; Bortnichak E; Vo T; Yu CL
    Pharmacoepidemiol Drug Saf; 2024 Aug; 33(8):e5851. PubMed ID: 39090803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Comparison of Real-World Databases for Conducting Research in Patients With Colorectal Cancer.
    Wang CY; Shao C; McDonald AC; Amonkar MM; Zhou W; Bortnichak EA; Liu X
    JCO Clin Cancer Inform; 2023 Jul; 7():e2200184. PubMed ID: 37437227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
    Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
    JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A data processing pipeline for the AACR project GENIE biopharma collaborative data with the {genieBPC} R package.
    Lavery JA; Brown S; Curry MA; Martin A; Sjoberg DD; Whiting K
    Bioinformatics; 2023 Jan; 39(1):. PubMed ID: 36519837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer.
    van la Parra RFD; Liao K; Smith BD; Yang WT; Leung JWT; Giordano SH; Kuerer HM
    JAMA Surg; 2018 Jun; 153(6):559-568. PubMed ID: 29387884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer of the Larynx-20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and ICD-O-3 Topographic Primary Sites-Codes C32.0-9: A Systematic Review of 43,103 Cases for Diagnosis Years 1975-2017: (NCI SEER*Stat 8.3.9).
    Milano AF
    J Insur Med; 2024 Jul; 51(2):92-110. PubMed ID: 39266004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
    Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
    Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime Occurrence of Brain Metastases Arising from Lung, Breast, and Skin Cancers in the Elderly: A SEER-Medicare Study.
    Ascha MS; Ostrom QT; Wright J; Kumthekar P; Bordeaux JS; Sloan AE; Schumacher FR; Kruchko C; Barnholtz-Sloan JS
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):917-925. PubMed ID: 31053636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
    Milano AF
    J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
    Kopelman ZA; Tian C; Tumas J; Phippen NT; Tarney CM; Hope ER; Winkler SS; Jokajtys S; Kucera CW; Chan JK; Richardson MT; Kapp DS; Hamilton CA; Leath CA; Jones NL; Rocconi RP; Farley JH; Secord AA; Cosgrove CM; Powell MA; Klopp A; Walker JL; Fleming GF; Bateman NW; Conrads TP; Maxwell GL; Darcy KM
    Gynecol Oncol; 2024 Apr; 183():103-114. PubMed ID: 38593674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
    Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
    BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung Cancer.
    Choudhury NJ; Lavery JA; Brown S; de Bruijn I; Jee J; Tran TN; Rizvi H; Arbour KC; Whiting K; Shen R; Hellmann M; Bedard PL; Yu C; Leighl N; LeNoue-Newton M; Micheel C; Warner JL; Ginsberg MS; Plodkowski A; Girshman J; Sawan P; Pillai S; Sweeney SM; Kehl KL; Panageas KS; Schultz N; Schrag D; Riely GJ;
    Clin Cancer Res; 2023 Sep; 29(17):3418-3428. PubMed ID: 37223888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry.
    Sanz-Garcia E; Brown S; Lavery JA; Weiss J; Fuchs HE; Newcomb A; Postle A; Warner JL; LeNoue-Newton ML; Sweeney SM; Pillai S; Yu C; Nichols C; Mastrogiacomo B; Kundra R; Schultz N; Kehl KL; Riely GJ; Schrag D; Govindarajan A; Panageas KS; Bedard PL
    Cancer Res Commun; 2024 Feb; 4(2):475-486. PubMed ID: 38329392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses - 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8).
    Milano AF
    J Insur Med; 2024 Jul; 51(2):77-91. PubMed ID: 39266003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of SEER Treatment Data With Medicare Claims.
    Noone AM; Lund JL; Mariotto A; Cronin K; McNeel T; Deapen D; Warren JL
    Med Care; 2016 Sep; 54(9):e55-64. PubMed ID: 24638121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of the Cancer Medications Enquiry Database (CanMED)-National Drug Codes (NDC): Assessment of Systemic Breast Cancer Treatment Patterns.
    Rivera DR; Grothen A; Ohm B; McNeel TS; Brennan S; Lam CJK; Penberthy L; Enewold L; Petkov VI
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):46-52. PubMed ID: 32412077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.